Earnings Call · Q2 FY2024·2024-08-09

Q2 24EPS -10.29%·Rev n/aQ1 24EPS +4.62%·Rev n/aQ4 23EPS +15.79%·Rev n/aQ3 23EPS +2.67%·Rev n/a⚠ consensus missing

Xenon Pharmaceuticals Inc. XENE

Chad Fugere — Unknown

Ian Mortimer — President and Chief Executive Officer

Chris Kenney — Chief Medical Officer

Sherry Aulin — Chief Financial Officer

−3.2%1d on move date−3.6% vs SPY3d−5.4%5d−6.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XENE calls or request research access.

More XENE calls Browse calls Request research access